Blog

Dec 7, 2024, 10:47

Rational CAR design for augmented T cell function – Journal for ImmunoTherapy of Cancer

Journal for ImmunoTherapy of Cancer shared the following on X:

“New JITC article: Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function.”

Rational CAR design for augmented T cell function - Journal for ImmunoTherapy of Cancer

Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function

Authors: Markus Barden, Patrick Ronan Elsenbroich, Vivian Haas, Moritz Ertelt, Philip Pervan, Lukas Velas, Bence Gergely, Árpád Szöőr, Dennis Christoph Harrer, Valerie Bezler, Astrid Holzinger, Rasmus Ulslev Wegener Friis, Gyorgy Vereb, Gerhard J Schütz, Clara T Schoeder, Andreas A Hombach, Hinrich Abken

Rational CAR design for augmented T cell function - Journal for ImmunoTherapy of Cancer

advanced therapies cancer Cancer research cancer treatment advancements CAR design CAR-T cell engineering immune responses immunotherapy Journal for ImmunoTherapy of Cancer OncoDaily Oncology Oncology Innovation T cell function

Giuliana Rancic and Breast Cancer: How She Went Against, How She Survived, and More

"The Doctor Who Always Has Candies in His Pocket": A Conversation with Professor Guangchao Zhang, Pioneer of Pediatric Surgical Oncology in China

Highlights from Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer - Day 3

Wanda Sykes and Breast Cancer: How She Went Against, How She Survived, and More

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Special Coverage